From off-period dystonia to peak-dose chorea: The clinical spectrum of varying subthalamic nucleus activity

The functional anatomy of basal ganglia disorders

1989 • 5,166 citations

Recent developments in Parkinson's disease

1986 • 2,266 citations

Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus

1990 • 1,875 citations

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

1998 • 1,826 citations

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

1991 • 1,712 citations

Aromatic Amino Acids and Modification of Parkinsonism

1967 • 1,464 citations

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

1994 • 1,352 citations

Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1995 • 1,340 citations

Modification of Parkinsonism — Chronic Treatment with L-Dopa

1969 • 1,253 citations

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders

1996 • 1,118 citations

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1992 • 1,088 citations

The basal ganglia

2000 • 1,053 citations

Core assessment program for intracerebral transplantations (CAPIT)

1992 • 999 citations

Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys

1993 • 609 citations

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

1998 • 607 citations

Treatment of Parkinsonism With Levodopa

1969 • 602 citations

Effect of GPi pallidotomy on motor function in Parkinson's disease

1995 • 600 citations

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot study

1996 • 566 citations

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1998 • 504 citations

Bilateral Chronic Electrostimulation of Ventroposterolateral Pallidum

1994 • 440 citations

Young onset Parkinson's disease

1987 • 436 citations

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

1969 • 403 citations

Stereotactic ventral pallidotomy for Parkinson's disease

1995 • 402 citations

A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease

1988 • 355 citations

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

1996 • 353 citations

Opposite motor effects of pallidal stimulation in Parkinson's disease

1998 • 332 citations

Globus pallidus internus pallidotomy for generalized dystonia

1997 • 324 citations

The response to levodopa in parkinson's disease: Imposing pharmacological law and order

1996 • 290 citations

Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment

1994 • 278 citations

Dopa‐responsive dystonia

1991 • 245 citations

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

1990 • 233 citations

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease

1998 • 228 citations

Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

1994 • 228 citations

Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification

1992 • 224 citations

Pallidotomy for generalized dystonia

1998 • 212 citations

PAINFUL PARKINSON'S DISEASE

1986 • 205 citations

Effects of apomorphine on globus pallidus neurons in parkinsonian patients

1997 • 191 citations

HEMICHOREA RESULTING FROM A LOCAL LESION OF THE BRAIN. (THE SYNDROME OF THE BODY OF LUYS

1927 • 186 citations

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients

1996 • 185 citations

Dystonia in parkinson's disease: Clinical and pharmacological features

1988 • 156 citations

Pathogenesis of dyskinesias in parkinson's disease

1989 • 151 citations

Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease.

1977 • 138 citations

Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.

1993 • 131 citations

Levodopa-induced dyskinesia and thalamotomy.

1984 • 129 citations

Six Years of High-Level Levodopa Therapy in Severely Akinetic Parkinsonian Patients

1976 • 116 citations

Pallidotomy for hemiballismus: Efficacy and characteristics of neuronal activity

1997 • 115 citations

Levodopa-induced dyskinesias in parkinsonian monkeys: Relationship to extent of nigrostriatal damage

1989 • 109 citations

“Early” initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

1991 • 108 citations

Early-Morning Dystonia

1979 • 106 citations

Does levodopa aggravate Parkinson's disease?

1988 • 104 citations

Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism

1971 • 104 citations

Nigrostriatal Damage is Required for Induction of Dyskinesias by l-DOPA in Squirrel Monkeys

1990 • 100 citations

Risk Factors for Peak Dose Dyskinesia in 100 Levodopa-treated Parkinsonian Patients

1996 • 98 citations

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

1998 • 96 citations

LONG-TERM SIDE-EFFECTS OF LEVODOPA

1971 • 85 citations

REVIEW

1994 • 82 citations

SURGICAL ALLEVIATION OF PARKINSONISM: EFFECTS OF OCCLUSION OF THE ANTERIOR CHOROIDAL ARTERY*

1954 • 81 citations

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.

1990 • 76 citations

Fluctuations of disability in Parkinson's disease: pathophysiology

1981 • 69 citations

Dystonic Foot Response of Parkinsonism

1980 • 66 citations

Suppression of dyskinesias in advanced Parkinson's disease: I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease

1993 • 64 citations

Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.

1996 • 64 citations

Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey

1993 • 63 citations

Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates

1996 • 44 citations

Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.

1992 • 43 citations

Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis

1997 • 38 citations

Painful dystonic spasms in Parkinson's disease.

1984 • 37 citations

PARALYSIS AGITANS;

1898 • 33 citations

Parkinson's disease and long-term levodopa therapy.

1987 • 33 citations

Chemopallidectomy and chemothalamectomy for parkinsonism.

1958 • 30 citations

The Pharmacology of Foot Dystonia in Parkinsonism

1987 • 29 citations

Pathophysiology of L-Dopa-Induced Abnormal Involuntary Movements

1985 • 29 citations

The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease.

1992 • 27 citations

DOPA-induced "peak dose" dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys.

1995 • 24 citations

Die Subthalamotomie zur Behandlung extrapyramidaler Bewegungsstörungen^*

1965 • 22 citations

The effect of subcortical lesions on production and alleviation of hemiballic or hemichoreic movements

1966 • 21 citations

Complex Dystonia of Parkinsonʼs Disease

1990 • 21 citations

Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology.

1987 • 18 citations

Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment

1994 • 18 citations